Evidence Library

Showing 10 of 397 results.
Jonathan Larsen, JD, MPP •
Center for Public Health Law Research
Elizabeth Platt, Esq. •
Center for Public Health Law Research

Coverage expansion for Medicaid improves access to care and health outcomes for people with substance use disorder (SUD). In spite of that evidence, as of May 2023, 10 states have failed to expand Medicaid funding to low-income adults as emergency enrollment protections established for COVID-19 end. This coverage gap in the non-expansion jurisdictions denies access to care to more than 1.9 million people living in Alabama, Florida, Georgia, Kansas, Mississippi, South Carolina, Tennessee, Texas, Wisconsin, and Wyoming.

 
Elizabeth Platt, Esq. •
Center for Public Health Law Research
Kathleen Moran-McCabe, JD •
Center for Public Health Law Research

This longitudinal dataset captures laws addressing authority to respond to public health emergencies that were enacted between May 21, 2022, and October 6, 2023, in all 50 US states and the District of Columbia. 

 
Elizabeth Platt, Esq. •
Center for Public Health Law Research
Kathleen Moran-McCabe, JD •
Center for Public Health Law Research

In April 2020, BroadStreet and The COVID-19 Data Project partnered with Temple University's Center for Public Health Law Research (CPHLR) to look longitudinally at executive orders, health directives, proclamations, and policies related to COVID-19.

 

To mitigate the risks associated with prescription opioid use, most states have implemented laws requiring clinicians to obtain informed consent prior to prescribing opioids in at least some circumstances. Informed consent is defined as a communication between a patient and clinician in which the patient agrees to a medical intervention after being informed of the risks, benefits, and alternatives.  

 
Scott Burris, JD •
Center for Public Health Law Research
Evan Anderson, JD •
Center for Public Health Initiatives, University of Pennsylvania

In this article in AMA Journal of Ethics​, Scott Burris and Evan Anderson outline the pandemic-era failures around the use of law for public health and offer recommendations and observations to facilitate a change in the culture and leadership of public health.

 
Elizabeth Platt, Esq. •
Center for Public Health Law Research
Kathleen Moran-McCabe, JD •
Center for Public Health Law Research
Amy Cook, JD •
Center for Public Health Law Research
Scott Burris, JD •
Center for Public Health Law Research

Published in the American Journal of Public Health, this article written by staff at the Center for Public Health Law Research identifies and categorizes US state legislation introduced between January 1, 2021, and May 20, 2022 that addresses emergency health authority. The COVID-19 pandemic called for quick, decisive action to limit infections, and when the next outbreak hits, new laws limiting health authority may make such action even more difficult.

 
Elizabeth Platt, Esq. •
Center for Public Health Law Research
Kathleen Moran-McCabe, JD •
Center for Public Health Law Research

State laws setting the scope and limits of emergency authority are crucial to an effective public health response. This suite of legal data captures details of legislation that addresses emergency health authority introduced between January 1, 2021, and May 20, 2022, in all 50 US states and the District of Columbia.

 
Elizabeth Platt, Esq. •
Center for Public Health Law Research
Caitlin Davie, JD •
CPHLR

This dataset presents state-level statutes and regulations on prescription drug monitoring program (PDMP) laws covering reporting requirements, mandates requiring providers to check PDMP databases before prescribing controlled substances, and provisions regulating access.  

 

Pages